Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brincidofovir in Progressive Multifocal Leukoencephalopathy
NCT07511049Phase 2Recruiting
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Jun 2026
- Primary completion
- Dec 2029
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of brincidofovir in progressive multifocal leukoencephalopathy (PML), sponsored by National Institute of Neurological Disorders and Stroke. Started Jun 2026; status: recruiting.
02
Drugs
brincidofovir
03
Conditions
progressive multifocal leukoencephalopathy (PML)
Beyond the preview
Go deeper on NCT07511049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07511049.